Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain

Arthritis Research and Therapy

Volumn 12, Issue 4, 2010, Pages

  Merky, Patrick ^a   Batsalova, Tsvetelina ^a   Bockermann, Robert ^b   Dzhambazov, Balik ^a   Sehnert, Bettina ^c   Burkhardt, Harald ^d   Bäcklund, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; COLLAGEN TYPE 2; EPITOPE; T LYMPHOCYTE RECEPTOR BETA CHAIN; CYTOKINE; GALACTOSE; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EFFECTOR CELL; INFLAMMATION; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; ANTIBODY SPECIFICITY; ARTHRITIS; CYTOLOGY; DBA MOUSE; FLOW CYTOMETRY; GENETICS; HYBRIDOMA; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; METHODOLOGY; RAT; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARTHRITIS, EXPERIMENTAL; COLLAGEN TYPE II; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; GALACTOSE; HYBRIDOMAS; IMMUNOPHENOTYPING; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; RATS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 77955098679     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3108     Document Type: Article

References (50)

1. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H. T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 1985, 22:295-306. 10.1111/j.1365-3083.1985.tb01884.x, 2413528.
2. Nandakumar KS, Backlund J, Vestberg M, Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res Ther 2004, 6:R544-R550. 10.1186/ar1217, 1064861, 15535832.
3. Lafaille JJ. T-cell receptor transgenic mice in the study of autoimmune diseases. J Autoimmun 2004, 22:95-106. 10.1016/j.jaut.2003.10.007, 14987736.
4. Brand DD, Myers LK, Whittington KB, Latham KA, Stuart JM, Kang AH, Rosloniec EF. Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J Immunol 2002, 168:490-498.
5. Osman GE, Cheunsuk S, Allen SE, Chi E, Liggitt HD, Hood LE, Ladiges WC. Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice. Int Immunol 1998, 10:1613-1622. 10.1093/intimm/10.11.1613, 9846690.
6. Mori L, Loetscher H, Kakimoto K, Bluethmann H, Steinmetz M. Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis. J Exp Med 1992, 176:381-388. 10.1084/jem.176.2.381, 2119315, 1386871.
7. Yamada H, Dzhambazov B, Bockermann R, Blom T, Holmdahl R. A transient post-translationally modified form of cartilage type II collagen is ignored by self-reactive T cells. J Immunol 2004, 173:4729-4735.
8. Backlund J, Nandakumar KS, Bockermann R, Mori L, Holmdahl R. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model. J Immunol 2003, 171:3493-3499.
9. Backlund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, Kihlberg J, Holmdahl R. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 2002, 32:3776-3784. 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A, 12516572.
10. Smith BD, Martin GR, Miller EJ, Dorfman A, Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975, 166:181-186. 10.1016/0003-9861(75)90378-1, 1122133.
11. Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990, 20:1061-1066. 10.1002/eji.1830200517, 1694131.
12. Michaelsson E, Andersson M, Engstrom A, Holmdahl R. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol 1992, 22:1819-1825. 10.1002/eji.1830220722, 1378019.
13. Krebber A, Bornhauser S, Burmester J, Honegger A, Willuda J, Bosshard HR, Pluckthun A. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods 1997, 201:35-55. 10.1016/S0022-1759(96)00208-6, 9032408.
14. Arenaz P, Sirover MA. Isolation and characterization of monoclonal antibodies directed against the DNA repair enzyme uracil DNA glycosylase from human placenta. Proc Natl Acad Sci USA 1983, 80:5822-5826. 10.1073/pnas.80.19.5822, 390167, 6577457.
15. Corthay A, Backlund J, Broddefalk J, Michaelsson E, Goldschmidt TJ, Kihlberg J, Holmdahl R. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998, 28:2580-2590. 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X, 9710235.
16. Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M, Scheffold A, Thiel A. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 2005, 11:1118-1124. 10.1038/nm1292, 16186818.
17. Goldschmidt TJ, Holmdahl R, Klareskog L. Depletion of murine T cells by in vivo monoclonal antibody treatment is enhanced by adding an autologous anti-rat kappa chain antibody. J Immunol Methods 1988, 111:219-226. 10.1016/0022-1759(88)90130-5, 3135334.
18. Holmdahl R, Carlsen S, Mikulowska A, Vestberg M, Brunsberg U, Hansson AS, Sundvall M, Jansson L, Pettersson U. Genetic analysis of mouse models for rheumatoid arthritis. Human Genome Methods 1998, 215-238. New York: CRC Press, Adolph KW.
19. Holmdahl R, Klareskog L, Andersson M, Hansen C. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 1986, 24:84-89. 10.1007/BF00373114, 3744440.
20. Bockermann R, Holmdahl R. Type II collagen without adjuvant induces eosinophilic arthritis. Eur J Immunol 2007, 37:540-548. 10.1002/eji.200636191, 17236234.
21. Huang JC, Vestberg M, Minguela A, Holmdahl R, Ward ES. Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers. Int Immunol 2004, 16:283-293. 10.1093/intimm/dxh039, 14734614.
22. Backlund J, Treschow A, Firan M, Malmstrom V, Issazadeh-Navikas S, Ward ES, Holmdahl R. Reversal of tolerance induced by transplantation of skin expressing the immunodominant T cell epitope of rat type II collagen entitles development of collagen-induced arthritis but not graft rejection. Eur J Immunol 2002, 32:1773-1783. 10.1002/1521-4141(200206)32:6<1773::AID-IMMU1773>3.0.CO;2-Z, 12115661.
23. Svendsen P, Andersen CB, Willcox N, Coyle AJ, Holmdahl R, Kamradt T, Fugger L. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. J Immunol 2004, 173:7037-7045.
24. Latham KA, Whittington KB, Zhou R, Qian Z, Rosloniec EF. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints. J Immunol 2005, 174:3978-3985.
25. Vollers SS, Stern LJ. Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 2008, 123:305-313. 10.1111/j.1365-2567.2007.02801.x, 2433336, 18251991.
26. Myers LK, Brand DD, Ye XJ, Cremer MA, Rosloniec EF, Bodo M, Myllyharju J, Helaakoski T, Nokelainen M, Pihlajaniemi T, Kivirikko K, Yang CL, Ala-Kokko L, Prockop DJ, Notbohm H, Fietzek P, Stuart JM, Kang AH. Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice. Immunology 1998, 95:631-639. 10.1046/j.1365-2567.1998.00637.x, 1364363, 9893056.
27. Myers LK, Myllyharju J, Nokelainen M, Brand DD, Cremer MA, Stuart JM, Bodo M, Kivirikko KI, Kang AH. Relevance of posttranslational modifications for the arthritogenicity of type II collagen. J Immunol 2004, 172:2970-2975.
28. Malherbe L, Filippi C, Julia V, Foucras G, Moro M, Appel H, Wucherpfennig K, Guery JC, Glaichenhaus N. Selective activation and expansion of high-affinity CD4+ T cells in resistant mice upon infection with Leishmania major. Immunity 2000, 13:771-782. 10.1016/S1074-7613(00)00075-3, 11163193.
29. Malherbe L, Hausl C, Teyton L, McHeyzer-Williams MG. Clonal selection of helper T cells is determined by an affinity threshold with no further skewing of TCR binding properties. Immunity 2004, 21:669-679. 10.1016/j.immuni.2004.09.008, 15539153.
30. Zehn D, Bevan MJ. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 2006, 25:261-270. 10.1016/j.immuni.2006.06.009, 2774714, 16879996.
31. Jenkins MK, Chu HH, McLachlan JB, Moon JJ. On the composition of the preimmune repertoire of T cells specific for peptide-major histocompatibility complex ligands. Annu Rev Immunol 2010, 28:275-294. 10.1146/annurev-immunol-030409-101253, 20307209.
32. Garcia Z, Pradelli E, Celli S, Beuneu H, Simon A, Bousso P. Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion. Proc Natl Acad Sci USA 2007, 104:4553-4558. 10.1073/pnas.0610019104, 1838639, 17360562.
33. Hataye J, Moon JJ, Khoruts A, Reilly C, Jenkins MK. Naive and memory CD4+ T cell survival controlled by clonal abundance. Science 2006, 312:114-116. 10.1126/science.1124228, 16513943.
34. Kedl RM, Rees WA, Hildeman DA, Schaefer B, Mitchell T, Kappler J, Marrack P. T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 2000, 192:1105-1113. 10.1084/jem.192.8.1105, 2195874, 11034600.
35. Corthay A, Backlund J, Holmdahl R. Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease. Ann Med 2001, 33:456-465. 10.3109/07853890109002094, 11680793.
36. Koenecke C, Chennupati V, Schmitz S, Malissen B, Forster R, Prinz I. In vivo application of mAb directed against the gammadelta TCR does not deplete but generates 'invisible' gammadelta T cells. Eur J Immunol 2009, 39:372-379. 10.1002/eji.200838741, 19130484.
37. Chiang EY, Kolumam GA, Yu X, Francesco M, Ivelja S, Peng I, Gribling P, Shu J, Lee WP, Refino CJ, Balazs M, Paler-Martinez A, Nguyen A, Young J, Barck KH, Carano RA, Ferrando R, Diehl L, Chatterjea D, Grogan JL. Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat Med 2009, 15:766-773. 10.1038/nm.1984, 19561618.
38. Cooper SM, Sriram S, Ranges GE. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ. J Immunol 1988, 141:1958-1962.
39. Mauritz NJ, Holmdahl R, Jonsson R, Van der Meide PH, Scheynius A, Klareskog L. Treatment with γ-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum 1988, 31:1297-1304. 10.1002/art.1780311012, 3140821.
40. Boissier MC, Chiocchia G, Bessis N, Hajnal J, Garotta G, Nicoletti F, Fournier C. Biphasic effect of interferon-γ in murine collagen-induced arthritis. Eur J Immunol 1995, 25:1184-1190. 10.1002/eji.1830250508, 7774621.
41. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J Immunol 1997, 158:5501-5506.
42. Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol 2001, 167:1004-1013.
43. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003, 171:6173-6177.
44. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004, 50:650-659. 10.1002/art.20001, 14872510.
45. Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, Ohsugi Y, Nishikawa T, Ripley B, Kimura A, Kishimoto T, Naka T. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses. Arthritis Rheum 2008, 58:3710-3719. 10.1002/art.24126, 19035481.
46. Lamacchia C, Palmer G, Seemayer CA, Talabot-Ayer D, Gabay C. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. Arthritis Rheum 2010, 62:452-462.
47. Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M, Kawabata D, Yukawa N, Hashimoto M, Sakaguchi N, Sakaguchi S, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Mimori T. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum 2009, 60:2294-2303. 10.1002/art.24687, 19644886.
48. Sarkar S, Cooney LA, White P, Dunlop DB, Endres J, Jorns JM, Wasco MJ, Fox DA. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-γ and IL-4. Arthritis Res Ther 2009, 11:R158. 10.1186/ar2838, 2787258, 19852819.
49. Roark CL, French JD, Taylor MA, Bendele AM, Born WK, O'Brien RL. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J Immunol 2007, 179:5576-5583. 2768546, 17911645.
50. Notley CA, Inglis JJ, Alzabin S, McCann FE, McNamee KE, Williams RO. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J Exp Med 2008, 205:2491-2497. 10.1084/jem.20072707, 2571924, 18936235.